Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors
EMPOWER-D-Afg
2 other identifiers
interventional
250
1 country
1
Brief Summary
This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 24, 2024
CompletedFirst Submitted
Initial submission to the registry
November 16, 2025
CompletedFirst Posted
Study publicly available on registry
January 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
January 20, 2026
January 1, 2026
1.9 years
November 16, 2025
January 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
To culturally adapt PLA-based intervention (D-Magic) for primary prevention and control of TIIDM in rural communities of Afghanistan
The outcome will measure the total number of Participatory Learning and Action (PLA) meetings conducted according to the adapted PLA manual. A total of 40 sessions are planned across four PLA groups (two male groups and two female groups), with 10 sessions per group. This measure will report the number of sessions completed as scheduled.
10 months
To test the feasibility of the culturally adapted PLA-based intervention (D-Magic)
Definition: Feasibility is measured by the number of participants attending PLA meetings, reflecting successful delivery and engagement. Measurement: Number of attendees (N) and proportion (%) of invited participants attending at least one PLA session.
12 months
To test the acceptability of the culturally adapted PLA-based intervention (D-Magic)
Definition: Acceptability is assessed by participant retention across PLA meetings, reflecting continued engagement and satisfaction with the intervention. Measurement: Number of participants completing the series of PLA meetings (N) and proportion (%) retained.
12 months
Secondary Outcomes (4)
To estimate the inter-correlation coefficient to inform future adjustment of sample size
6 months
To identify and examine potential Barriers to Implementation of the PLA-Based Intervention
12 months
To identify and examine potential facilitators of Implementation of the PLA-Based Intervention
12 months
To assess the frequency of Type 2 Diabetes and Intermediate Hyperglycaemia
12 months
Study Arms (2)
PLA Intervention group
EXPERIMENTALParticipatory Learning and Action (PLA) sessions adapted from the D-MAGIC trial (Bangladesh). The PLA intervention will be delivered to community members with type II diabetes to improve diabetes-related outcomes. Sessions will be group-based, lasting approximately 2-3 hours each. Participants in this arm will be followed and evaluated 10 months after the start of the intervention using a structured, validated, literature-based endline assessment checklist to assess feasibility and outcomes.
Usual care (control) group
NO INTERVENTIONParticipants in the control arm will receive standard practice (usual care) and comprehensive information about the project but will not receive the PLA intervention.
Interventions
An PLA based intervention would be carried out to prepare the individuals with TIIDM. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the community. The study participants would be evaluated after completion of 10 months of the intervention. A structured, validated and literature-based end line assessment checklist will be devised to assess the feasibility of the intervention.
Eligibility Criteria
You may qualify if:
- For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.
- Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.
- All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.
- Participants who can attend the scheduled meetings and interventions as per the study protocol.
You may not qualify if:
- For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.
- Individuals unwilling to provide consent for participation.
- Participants with reported health conditions that may hinder their active involvement in the study.
- Individuals with non-compliance with research protocols
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HealthNet Transcultural Psychosocial Organizationlead
- University of Yorkcollaborator
- Khyber Medical University Peshawarcollaborator
- National Institute for Health Research, United Kingdomcollaborator
- Aga Khan Universitycollaborator
Study Sites (1)
HealthNet TPO, Afghanistan
Kabul, Kabul, 24000, Afghanistan
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abdul Rahman Shahab, MPH
Deputy Country Director, HealthNet TPO, Afghanistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research coordinator, HealthNet TPO
Study Record Dates
First Submitted
November 16, 2025
First Posted
January 20, 2026
Study Start
December 24, 2024
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
September 30, 2027
Last Updated
January 20, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Data requests can be submitted starting 12 months after article publication
- Access Criteria
- Access can be requested by qualified researchers through proper approval of the investigators.
Data obtained through this study may be provided to qualified researchers with academic interest in the stated study area after its proper monitoring. Data or samples shared will be coded, with no Protected Health Information included. Prior permission of the investigators, participants and concerned departments will be obtained.